Dan Feng1, Wen-Hua Ling, Rui-Dong Duan. 1. Department of Nutrition, School of Public Health, Sun Yat-sen University (Northern Campus), 74 Zhongshan Road 2, 510080 Guangzhou, People's Republic of China.
Abstract
BACKGROUND: Lycopene has antioxidant, anticancer, and anti-inflammatory effects with molecular mechanisms not fully identified. AIM AND METHODS: We investigated the effects of lycopene on the inflammatory responses to lipopolysaccharide (LPS) in RAW264.7 cells and the signal transduction pathways involved. RESULTS: Lycopene inhibited LPS-induced production of nitric oxide (NO) and interleukin-6 (IL-6) with decreased mRNAs of inducible nitric oxide synthase and IL-6 but had no effect on TNF-alpha. Further study showed that lycopene also inhibited LPS-induced IkappaB phosphorylation, IkappaB degradation, and NF-kappaB translocation. Moreover, lycopene blocked the phosphorylation of ERK1/2 and p38 MAP kinase but not c-Jun NH(2)-terminal kinase. To confirm the causal link between MAP kinase inhibition and its anti-inflammatory effects, we treated the cells with SB 203580 and U0126. These inhibitors significantly inhibited LPS-induced NO and IL-6 formation. CONCLUSION: Lycopene inhibits the inflammatory response of RAW 264.7 cells to LPS through inhibiting ERK/p38 MAP kinase and the NF-kappaB pathway.
BACKGROUND:Lycopene has antioxidant, anticancer, and anti-inflammatory effects with molecular mechanisms not fully identified. AIM AND METHODS: We investigated the effects of lycopene on the inflammatory responses to lipopolysaccharide (LPS) in RAW264.7 cells and the signal transduction pathways involved. RESULTS:Lycopene inhibited LPS-induced production of nitric oxide (NO) and interleukin-6 (IL-6) with decreased mRNAs of inducible nitric oxide synthase and IL-6 but had no effect on TNF-alpha. Further study showed that lycopene also inhibited LPS-induced IkappaB phosphorylation, IkappaB degradation, and NF-kappaB translocation. Moreover, lycopene blocked the phosphorylation of ERK1/2 and p38 MAP kinase but not c-Jun NH(2)-terminal kinase. To confirm the causal link between MAP kinase inhibition and its anti-inflammatory effects, we treated the cells with SB 203580 and U0126. These inhibitors significantly inhibited LPS-induced NO and IL-6 formation. CONCLUSION:Lycopene inhibits the inflammatory response of RAW 264.7 cells to LPS through inhibiting ERK/p38 MAP kinase and the NF-kappaB pathway.
Authors: Ahmad Saedisomeolia; Lisa G Wood; Manohar L Garg; Peter G Gibson; Peter A B Wark Journal: J Nutr Biochem Date: 2008-09-27 Impact factor: 6.048
Authors: Marwa Ahmed Abass; Shereen Ahmed Elkhateeb; Samia Adel Abd El-Baset; Asmaa Alhosiny Kattaia; Eman Mosallam Mohamed; Hebatallah Husseini Atteia Journal: Environ Sci Pollut Res Int Date: 2016-04-22 Impact factor: 4.223
Authors: Subash C Gupta; Ji Hye Kim; Ramaswamy Kannappan; Simone Reuter; Patrick M Dougherty; Bharat B Aggarwal Journal: Exp Biol Med (Maywood) Date: 2011-05-12
Authors: N Ben Amara; F Tourniaire; M Maraninchi; N Attia; M J Amiot-Carlin; D Raccah; R Valéro; J F Landrier; P Darmon Journal: Eur J Nutr Date: 2014-06-07 Impact factor: 5.614